Celebrex - Celecoxib capsules - Pfizer - COX-2 inhibitor approved for ankylosing spondylitis

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:296 / 296
页数:1
相关论文
共 50 条
  • [21] Determination of celecoxib, a COX-2 inhibitor, in pharmaceutical dosage forms by MEKC
    Srinivasu, MK
    Rao, DS
    Reddy, GO
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (3-4) : 493 - 500
  • [22] A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study
    Elaine S Rogers
    Roderick D MacLeod
    Joanna Stewart
    Stephen P Bird
    Justin WL Keogh
    BMC Cancer, 11
  • [23] A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study
    Rogers, Elaine S.
    MacLeod, Roderick D.
    Stewart, Joanna
    Bird, Stephen P.
    Keogh, Justin W. L.
    BMC CANCER, 2011, 11
  • [24] Application of light emitting diode and Celecoxib (Cox-2 inhibitor) for the management of wounds
    Thng, S. T.
    Manoj, K.
    Tan, M.
    Chow, P.
    Moochhala, S. M.
    Lu, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S135 - S135
  • [25] Efficacy, tolerability, and safety of celecoxib, a specific COX-2 inhibitor, in osteoarthritis.
    Hubbard, R
    Geis, GS
    Woods, E
    Yu, S
    Zhao, W
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S196 - S196
  • [26] Application of light emitting diode and celecoxib (Cox-2 inhibitor) for the management of wounds
    Thng, S.
    Lu, J.
    Moochala, S.
    Kumar, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S255 - S255
  • [27] Efficacy of celecoxib. A cox-2 specific inhibitor, in osteoarthritis of the hip.
    Geis, GS
    Hubbard, RC
    Woods, EM
    Lefkowith, JB
    Yu, S
    Zhao, W
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S144 - S144
  • [28] The COX-2 inhibitor celecoxib and its use in the management of prostate cancer.
    Sooriakumaran, Prasanna
    Mehar, Ayaz
    Macanas-Pirard, Patricia
    Langley, Stephen
    Laing, Robert
    Lovell, David
    Coley, Helen
    CANCER RESEARCH, 2006, 66 (08)
  • [29] COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib
    Grösch, S
    Tegeder, I
    Niederberger, E
    Bräutigam, L
    Geisslinger, G
    FASEB JOURNAL, 2001, 15 (12): : 2742 - +
  • [30] Application of Light Emitting Diode and Celecoxib (Cox-2 inhibitor) for the Management of Wounds
    Thng, Steven
    Tan, Mui Hong
    Chow, Pierce
    Moochala, Shabbir
    Lu, Jia
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S57 - S57